Compare Neurocrine Biosciences Inc (NBIX) vs TE Connectivity plc Ordinary Shares (TEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs TE Connectivity plc Ordinary Shares — how do they compare? Neurocrine Biosciences Inc trades at $141.66 (market cap $14.36B), while TE Connectivity plc Ordinary Shares trades at $215.56 (market cap $62.05B). The key difference: TE Connectivity plc Ordinary Shares is far larger — about 4.3× Neurocrine Biosciences Inc's market cap, and TE Connectivity plc Ordinary Shares pays a 1.46% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | TEL | |
|---|---|---|
Market Cap | $14.36B | $62.05B |
Volume | 1,237,180 | 1,425,198 |
Sector | Health | Technology |
52-Week High | $185.50 | $249.00 |
52-Week Low | $123.10 | $195.84 |
Typical Hold Time | 23 Days | — |
Enterprise Value | $14.37B | $66.44B |
Dividend Yield | — | 1.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Neurocrine Biosciences (NBIX) trades at $141.69, down 1.24% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 20.91% net income margin and consistent earnings beats, including a significant Q2 2026 beat. Recent news highlights pipeline advancements and executive appointments, while analyst sentiment remains overwhelmingly positive.
The outlook for NBIX is supported by robust fundamentals and strong analyst buy ratings, but near-term price action is challenged by technical bearishness. Key opportunities include product diversification and pipeline growth, while risks involve execution of expansion plans and potential pricing pressures on key products like INGREZZA.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About TE Connectivity plc Ordinary Shares
TE Connectivity designs and manufactures connectivity and sensor solutions. Its products support transportation, energy networks, industrial automation, communications infrastructure, and medical technology.
Read more on TEL →
